NanoString sees Q4 revenue of $30M, consensus $28.55M
NanoString sees Q4 product and service revenue of approximately $23.5M, exceeding the upper end of the company's guidance range of $22M-$23M. Sees FY18 product and service revenue of approximately $83.5M, exceeding the upper end of the company's guidance range of $82M-$83M. Sees Q4 total revenue of $30M, including approximately $6M of collaboration revenue, versus prior guidance of $28M-$29M. Consensus at $28.5M. Sees FY18 total revenue of $106M-$107M, including approximately $23M of collaboration revenue, versus prior guidance of $104M-$106M. Consensus at 105.2M. Cash, cash equivalents and short-term investments totaled more than $90M as of December 31, 2018. NanoString president and chief executive officer, Brad Gray, will give a corporate update at the JPMorgan Healthcare conference on Wednesday January 9th, 2019.